NBP
$2.56-0.14 (-5.01%)
Market ClosedAs of Mar 20, 8:00 PM UTC
NovaBridge Biosciences, a biotech company, focuses on the development of immuno-oncology agents for the treatment of cancer in the United States.
Recent News
Amazon downgraded, Roblox upgraded: Wall Street's top analyst calls
Amazon downgraded, Roblox upgraded: Wall Street's top analyst calls
Insider Spends US$5.1m Buying More Shares In NovaBridge Biosciences
NovaBridge Biosciences ( NASDAQ:NBP ) shareholders (or potential shareholders) will be happy to see that the Executive...
Is There An Opportunity With NovaBridge Biosciences' (NASDAQ:NBP) 40% Undervaluation?
Key Insights The projected fair value for NovaBridge Biosciences is US$6.70 based on 2 Stage Free Cash Flow to Equity...
Companies Like NovaBridge Biosciences (NASDAQ:NBP) Can Afford To Invest In Growth
Just because a business does not make any money, does not mean that the stock will go down. By way of example...